(ATN) Hypericum Update

DonateNow
Print this article

(ATN) Hypericum Update

AIDS TREATMENT NEWS No. 064 - September 9, 1988
John S. James


The major article in the last issue of AIDS Treatment News concerned hypericum (St. John's wort), a medicinal herb containing an ingredient which showed strong anti-retroviral activity in animal tests.

Hypericum, considered moderately safe but not totally safe by herbalists, has long been used for other medicinal purposes, and various preparations are available in some health-food stores. But there are doubts whether they contain enough hypericin, the active ingredient, to be useful. And so far we do not have even anecdotal reports of human use for AIDS or HIV; no one has yet said that they think the herb did (or did not) help them, because no one has used it long enough. For these reasons, we do not think this potential treatment is ready for widespread use, until there is more experience with it.

A few people are trying different extracts at this time. Also we have learned that chemical testing to compare the extracts should be inexpensive, around $30. for each sample analyzed. However we have not yet obtained a "standard", a sample of the pure chemical to calibrate the testing equipment; without the standard, the laboratory can compare the concentrations of hypericin in different extracts, but cannot accurately measure absolute amounts.

If you are using hypericum, or could help us test or research it, please call John or Denny at AIDS Treatment News, (415) 255-0588, to help us pool information for everyone's benefit.


880909
ATN06403


Copyright © 1988 - AIDS Treatment News. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. AIDS Treatment News, Subscription and Editorial Office: 1233 Locust St., 5th floor Philadelphia, PA 19107 800/TREAT-1-2 toll-free email: aidsnews@critpath.org  http://www.aidsnews.org

Subscription Information: Call 800/TREAT-1-2: Businesses, Institutions, Professionals: $270/year. Includes early delivery of an extra copy by email. Nonprofit organizations: $135/year. Includes early delivery of an extra copy by email. Individuals: $120/year, or $70 for six months. Special discount for persons with financial difficulties: $54/year, or $30 for six months. If you cannot afford a subscription, please write or call. Outside North, Central, or South America, add air mail postage: $20/year, $10 for six months. Back issues available. Fax subscriptions, bulk rates, and multiple subscriptions are available; contact our office for details. Please send U.S. funds: personal check or bank draft, international postal money order, or travelers checks. VISA, Mastercard, and purchase orders also accepted. ISSN # 1052-4207

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .